false
0001750153
0001750153
2024-01-31
2024-01-31
0001750153
us-gaap:CommonStockMember
2024-01-31
2024-01-31
0001750153
us-gaap:WarrantMember
2024-01-31
2024-01-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of report (Date of earliest event reported):
January 31, 2024
CANOO INC.
(Exact name of registrant as specified in its
charter)
Delaware
(State
or Other Jurisdiction
of Incorporation) |
001-38824
(Commission
File Number) |
82-1476189
(I.R.S. Employer
Identification Number) |
19951 Mariner Avenue
Torrance,
California |
90503 |
| (Address of principal executive offices) |
(Zip Code) |
(424) 271-2144
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each
class |
|
Trading
symbol(s) |
|
Name of each
exchange
on which registered |
| Common Stock, $0.0001 par value per share |
|
GOEV |
|
The Nasdaq Capital Market |
| |
|
|
|
|
| Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share |
|
GOEVW |
|
The Nasdaq Capital Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
| Item 1.01 |
Entry into a Material Definitive Agreement. |
Seventh Supplemental Agreement
On July 20, 2022, Canoo Inc. (the “Company”)
entered into a Pre-Paid Advance Agreement (as amended and supplemented from time to time, the “PPA”) with YA II
PN, Ltd. (“Yorkville”). In accordance with the terms of the PPA, the Company may request advances of up to $50,000,000
in cash from Yorkville (or such greater amount that the parties may mutually agree).
On January 31, 2024 (the “Effective Date”),
the Company entered into a seventh Supplemental Agreement (the “Seventh Supplemental Agreement”) with Yorkville to
the PPA. Pursuant to the Seventh Supplemental Agreement, Yorkville agreed to advance $20,000,000 to the Company (the “Seventh
Supplemental Advance”) and waive certain terms and conditions set forth in the PPA with respect to such Supplemental Advance.
After giving effect to the commitment fee and the purchase price discount provided for in the PPA, net proceeds of the Seventh Supplemental
Advance to the Company will be $18,800,000.
The Seventh Supplemental Agreement provides that
solely with respect to the Seventh Supplemental Advance, the Purchase Price (as such term is used in the PPA) will be equal to the lower
of (a) $0.1805 per share, or (b) 95% of the lowest daily VWAP during five Trading Days immediately preceding each Purchase Notice Date
(as such term is used in the PPA), but not lower than the Floor Price (as defined in the PPA). Further, the Company agreed to pay Yorkville
a commitment fee of $1,000,000 in connection with the Seventh Supplemental Agreement, which shall be deducted from the proceeds of the
Seventh Supplemental Advance.
The foregoing description of the Seventh Supplemental
Agreement does not purport to be complete and is qualified in its entirety by reference to the Seventh Supplemental Agreement, which is
filed hereto as Exhibit 10.1 and which is incorporated herein by reference.
Warrant Cancellation and Exchange Agreement
On the Effective Date, the Company and
Yorkville entered into a Warrant Cancellation and Exchange Agreement (the “WC&E
Agreement”). Pursuant to the WC&E Agreement, on the Effective Date, Yorkville surrendered to the Company and the
Company cancelled all outstanding warrants issued pursuant to agreements with Yorkville, dated June 30, 2023, August 2, 2023, and
September 26, 2023, respectively (collectively, the “Outstanding
Warrants”), which Outstanding Warrants represented the right to purchase an aggregate of 127,270,416 shares of the
Company’s common stock, par value $0.0001 per share (“Common
Stock”), and in exchange, the Company issued to Yorkville (i) a warrant to purchase 110,803,324 shares of Common Stock
at an exercise price of $0.1805, exercisable beginning on July 31, 2024 and with an expiration date of February 1, 2029 (the
“First Warrant”) and (ii) a warrant to purchase 127,270,416 shares of
Common Stock at an exercise price of $0.1805, exercisable beginning on July 31, 2024 and with an expiration date of February 1, 2029
(the “Second Warrant” and together with the First Warrant, collectively,
the “New Warrants”). The New Warrants include customary adjustment
provisions for stock splits, combinations and similar events.
The foregoing descriptions of the WC&E Agreement
and the New Warrants do not purport to be complete and are qualified in their entirety by reference to the full text of such documents,
which are filed hereto as Exhibits 10.2 and 4.1, respectively, and which are incorporated herein by reference.
| Item 3.02 | Unregistered
Sales of Equity Securities. |
The
information contained in Item 1.01 is incorporated herein by reference. The issuance of the New Warrants is exempt from registration
pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). Yorkville represented
to the Company that they are each an “accredited investor” as defined in Rule 501 of the Securities Act and that the New
Warrants are being acquired for investment purposes and not with a view to, or for sale in connection with, any distribution thereof.
| Item 9.01 | Financial
Statements and Exhibits. |
(d) Exhibits
The following exhibits are filed herewith:
Forward-Looking Statements
This report contains forward-looking statements,
and any statements other than statements of historical fact could be deemed to be forward-looking statements. These forward-looking statements
include, among other things, statements regarding the amount of shares of common stock the Company may issue to Yorkville pursuant to
the Seventh Supplemental Advance, the amount of proceeds to be received by the Company from the sale of shares of common stock and the
uses thereof and related matters. These statements are subject to risks and uncertainties, and actual results may differ materially from
these statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of
this report. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances
after the date hereof.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: January 31, 2024 |
CANOO INC. |
| |
|
|
| |
By: |
/s/ Hector Ruiz |
| |
Name: |
Hector Ruiz |
| |
Title: |
General Counsel and Corporate Secretary |
Exhibit 10.1
SUPPLEMENTAL AGREEMENT
This Supplemental Agreement
(this “Agreement”), dated as of January 31, 2024, is entered into by and between YA II PN, LTD., a Cayman Islands
exempt limited partnership (the “Investor”), CANOO INC., a corporation organized and existing under the laws
of the State of Delaware (the “Company”). Capitalized terms not otherwise defined herein shall have the meanings set
forth in the Pre-Paid Advance Agreement (as defined below).
BACKGROUND
| (A) | On July 20, 2022, the parties entered into that Pre-Paid Advance Agreement (the “Pre-Paid Advance
Agreement”) pursuant to which the Company may, provided that the conditions
precedent to a Pre-Paid Advance set forth in Section 2.02 are then satisfied, request a Pre-Paid Advance in an amount not to exceed
the Maximum Advance Amount from the Investor by providing a written Request. |
| (B) | On November 9, 2022, the parties entered into a Supplemental Agreement (the “First Supplemental
Agreement”) pursuant to which the Investor agreed to advance $21,300,00 (the “Third Pre-Paid Advance”) to
the Company and waive certain terms and conditions set forth in the Pre-Paid Advance Agreement. |
| (C) | On December 31, 2022, the parties entered into a Second Supplemental Agreement (the “Second Supplemental
Agreement”) pursuant to which the Investor agreed to advance $34,045,500, with an option to increase such advance by up to an
additional $8,514,500 (collectively, the “Fourth Pre-Paid Advance”) to the Company and waive certain terms and conditions
set forth in the Pre-Paid Advance Agreement. |
| (D) | On January 24, 2023 the Company obtained consent of the shareholders of the Company (i) for the issuance
of all shares of its Common Stock that could be issued pursuant to the Pre-Paid Advance Agreement pursuant to Nasdaq Listing Rule 5636(d),
and (ii) to amend the Pre-Paid Advance Agreement to provide a Floor Price of $0.50 per share (such consents, the “First Shareholder
Approval”). Upon such First Shareholder Approval, the Company implemented a reduction to the Floor Price to $0.50 per share. |
| (E) | On September 11, 2023, the parties entered into a Third Supplemental Agreement (the “Third Supplemental
Agreement”) pursuant to which the Investor agreed to advance $12,500,000 (the “Fifth Pre-Paid Advance”) to
the Company and waive certain terms and conditions set forth in the Pre-Paid Advance Agreement. |
| (F) | On October 5, 2023, the Company obtained consent of the shareholders of the Company to amend the Pre-Paid
Advance Agreement to provide a Floor Price of $0.10 per share (such consent, the “Second Shareholder Approval”). Upon
such Second Shareholder Approval, the Company implemented a reduction to the Floor Price to $0.10 per share. |
| (G) | On November 21, 2023, the parties entered into a Fourth Supplemental Agreement (the “Fourth Supplemental
Agreement”) pursuant to which the Investor agreed to advance $21,276,600 (the “Sixth Pre-Paid
Advance”) to the Company and waive certain terms and conditions set forth in the Pre-Paid Advance Agreement. |
| (H) | On December 20, 2023, the parties entered into a Fifth Supplemental Agreement (the “Fifth Supplemental
Agreement”) pursuant to which the Investor agreed to advance $15,957,447 (the “Seventh Pre-Paid Advance”)
to the Company and waive certain terms and conditions set forth in the Pre-Paid Advance Agreement. |
| (I) | On January 11, 2024, the parties entered into a Sixth Supplemental Agreement (the “Sixth Supplemental
Agreement”) pursuant to which the Investor agreed to advance $17,500,000 (the “Eighth Pre-Paid Advance”)
to the Company and waive certain terms and conditions set forth in the Pre-Paid Advance Agreement. |
| (J) | Pursuant to this Agreement, the parties desire to supplement the terms and conditions of the Pre-Paid
Advance Agreement in respect of a Request for a Pre-Paid Advance in the amount of $20,000,000 (the “Ninth Request”)
to be provided by the Company to the Investor concurrently with the execution of this Agreement. This Agreement shall govern the Ninth
Pre-Paid Advance (as defined below). |
| (K) | As of the date hereof, except for the principal outstanding balance of $12,000,000 pursuant to the Sixth
Pre-Paid Advance and the full outstanding balances of the Seventh Pre-Paid Advance and the Eighth Pre-Paid Advance, none of the prior
Pre-Paid Advances remain outstanding. |
NOW, THEREFORE, in
consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:
| 1. | Ninth Pre-Paid Advance Amount |
1.1. The
Company has requested, and the Investor has agreed to fund, a ninth Pre-Paid Advance in the amount of $20,000,000 (the “Ninth
Pre-Paid Advance”). The Ninth Pre-Paid Advance shall be governed by the terms and conditions of the Pre-Paid Advance Agreement,
except as set forth in this Agreement. Solely with respect to the Ninth Pre-Paid Advance, the parties hereby agree as follows:
| (a) | The Pre-Advance Date in respect to the Ninth Pre-Paid Advance shall be January 31, 2024. |
| (b) | The Purchase Price shall mean the lower of (a) $0.1805 per share (the “Fixed Price”),
or (b) 95% of the lowest daily VWAP during five Trading Days immediately preceding each Purchase Notice Date, but not lower than the Floor
Price. |
| (c) | Section 3.01(h) of the Pre-Paid Advance Agreement shall not apply in respect of the Ninth Pre-Paid Advance. |
| (d) | The Company hereby agrees to pay the Investor a commitment fee of $1,000,000, which amount shall be deducted
by the Investor from the proceeds of the Ninth Pre-Paid Advance. |
(a) Solely
with respect to the Ninth Request, the Investor hereby waives the application of the conditions precedent set forth Section 2.02(k).
| 1.3 | Additional Agreements. |
(a) For
the avoidance of doubt, any failure by the Company to observe or perform any material covenant, agreement or warranty contained in (i)
this Agreement, (ii) the First Supplemental Agreement, (iii) the Second Supplemental Agreement, (iv) the Third Supplemental Agreement,
(v) the Fourth Supplemental Agreement, (vi) the Fifth Supplemental Agreement, (vii) the Sixth Supplemental Agreement or (viii) any other
agreement between the parties hereof shall be an Event of Default under the Pre-Paid Advance Agreement.
| 2. | Representations, Warranties and Covenants. |
2.1 Representations
and Warranties. Each party represents and warrants to the other as of the date of this Agreement that:
| (a) | it has the requisite corporate power and authority to enter into this Agreement and to consummate the
transactions contemplated by this Agreement; |
| (b) | it has taken all necessary corporate actions to authorize the execution, delivery and performance of this
Agreement and no further action is required by the it, its Board of Directors or managers or members in connection therewith; and |
| (c) | the obligations assumed by it in this Agreement are legal, valid, and enforceable obligations binding
on it in accordance with its terms. |
2.2 The
Company represents and warrants that as of January 30, 2024, the authorized capital stock of the Company consists of 2,000,000,000 shares
of Common Stock, of which 1,034,222,953 are issued and outstanding.
2.3 Cleansing
Disclosures. As soon as possible (and prior to the open of business on February 1, 2024) the Company shall file with the SEC a
report on Form 8-K or such other appropriate form as determined by counsel to the Company, relating to the transactions contemplated
by this Agreement disclosing all information relating to the transaction contemplated hereby required to be disclosed therein,
disclosing all information relating to the closing of the Ninth Pre-Paid Advance required to be disclosed therein (collectively, the
“Cleansing Disclosure”). From and after the issuance of the Cleansing Disclosure, the Company represents to the
Investor that it shall have publicly disclosed all material, non-public information delivered to the Investor by the Company in
connection with the transactions contemplated by this Agreement and the Pre-Paid Advance Agreement. The Company promptly shall
prepare and file with the SEC a preliminary Prospectus Supplement pursuant to Rule 424(b) of the Securities Act and an updated Plan
of Distribution, necessary to register the transactions contemplated herein, including, without limitation, all shares of Common
Stock issuable pursuant to the Ninth Pre-Paid Advance, and any other filings, reports, supplements, or amendments that may be
required to keep the Registration Statement and related Prospectus Supplements used in connection with such Registration Statement
updated and effective, including, without limitation, the continued use of the Prospectus in connection with the Ninth Pre-Paid
Advance.
2.4 The
Company shall at all times reserve 110,000,000 shares of Common Stock for issuance to the Investor in connection with the Ninth Pre-Paid
Advance. Upon the repayment in full of the outstanding balance under the Sixth Pre-Paid Advance, the Seventh Pre-Paid Advance, or the
Eighth Pre-Paid Advance, any shares of Common Stock that remain reserved in connection with such Pre-Paid Advance shall be transferred
to the reserve for the Ninth Pre-Paid Advance.
2.5 The
Company represents and warrants that the issuance of Common Shares to the Investor under the Pre-Paid Advance Agreement in respect of
the Ninth Pre-Paid Advance are not subject to the Exchange Cap as a result of the Company obtaining the Shareholder Approval in accordance
with Nasdaq Listing Rule 5636(d).
2.6 Upon
request from the Investor, the Company shall call and hold a special meeting of its shareholders as soon possible following receipt of
such request for the purposes of obtaining the consent of its shareholders to amend the Pre-Paid Advance Agreement to reduce the Floor
Price to a price to be agreed upon with the Investor. In connection with such meeting, the Company shall solicit proxies from its shareholders
in connection therewith and management-appointed proxyholders shall vote their proxies in favor of such proposal. The Company shall file
a preliminary proxy relating to such proposal as soon as possible following receipt of the aforementioned request from the Investor. Upon
obtaining such shareholder approval, the Company shall promptly implement such reduction of the Floor Price.
3. Counterparts
and delivery. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such “.pdf” signature page were an original thereof.
4. Governing
law. This Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New
York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction
of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by
mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the
address in effect for notices to it under the Second Purchase Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any other manner permitted by law.
[REMAINDER OF PAGE INTENTIONALLY
LEFT BLANK]
IN WITNESS WHEREOF,
the parties hereto have caused this Supplemental Agreement to be signed by their duly authorized officers.
| |
COMPANY: |
| |
|
| |
CANOO INC. |
| |
|
| |
By: |
/s/ Tony Aquila |
| |
Name: |
Tony Aquila |
| |
Title: |
Chief Executive Officer |
| |
|
| |
INVESTOR: |
| |
|
| |
YA II PN, LTD. |
| |
|
| |
By: |
Yorkville Advisors Global LP |
| |
Its: |
Investment Manager |
| |
|
By: |
Yorkville Advisors Global II, LLC |
| |
|
Its: |
General Partner |
| |
|
| |
By: |
/s/ Matt Beckman |
| |
Name: |
Matt Beckman |
| |
Title: |
Member |
Exhibit 10.2
WARRANT CANCELLATION AND EXCHANGE AGREEMENT
This WARRANT CANCELLATION
AND EXCHANGE AGREEMENT (this “Agreement”) is made as of January 31, 2024, by and between Canoo Inc., a Delaware corporation
(the “Company”), and YA II PN, Ltd. (“Warrant Holder”).
WHEREAS, pursuant to that
certain (i) Warrant Agreement, dated June 30, 2023, by and between the Company and Warrant Holder, (ii) Warrant Agreement, dated August
2, 2023, by and between the Company and Warrant Holder, and (iii) Warrant Agreement, dated September 26, 2023, by and between the Company
and Warrant Holder, Warrant Holder is the holder of and has the right to purchase in the aggregate amount equal to 127,270,416 shares
of the Company’s common stock, par value $0.0001 per share the Company (“Common Stock”) at an exercise price
of $0.5358 (collectively, the “Prior Warrants”); and
WHEREAS, the Company and Warrant
Holder intend to enter into this Agreement pursuant to which the Prior Warrants shall be surrendered by Warrant Holder and cancelled as
of the date hereof and, in return, the Company shall issue the following warrants to Warrant Holder, each in the form attached hereto
as Exhibit A, as follows: (a) a warrant to purchase 110,803,324 shares of Common Stock at an exercise price of $0.1805 (the
“First Warrant”) and (b) a warrant to purchase 127,270,416 shares of Common Stock at an exercise price of $0.1805 (the
“Second Warrant” and together with the First Warrant, collectively, the “New Warrants”).
NOW, THEREFORE, in consideration
of the premises and the mutual promises herein and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereby agree as follows:
1.
Cancellation of the Prior Warrants and Issuance of the New Warrants.
(a)
Warrant Holder hereby surrenders the Prior Warrants, which Prior Warrants shall be cancelled and deemed null and void in
all respects, effective or deemed effective on the date hereof, and in exchange for the Prior Warrants, the Company hereby issues to Warrant
Holder the New Warrants, each of which shall be deemed as validly issued and not assessable, effective immediately upon such issuance.
(b)
Warrant Holder agrees that the issuance of the New Warrants in exchange for surrender of the Prior Warrants constitutes
full and fair consideration for the termination of the Prior Warrants and shall be deemed to satisfy all of the Company’s obligations
under the Prior Warrants.
(c)
It is hereby agreed and acknowledged that as of the date hereof, the Prior Warrants shall have been cancelled in full and
rendered null and void, and all past, current, or future obligations of the parties solely with respect to the Prior Warrants shall have
been extinguished. Warrant Holder acknowledges and agrees that as of the date hereof, it shall have no surviving right, title or interest
in or to the Prior Warrants.
2.
Representations and Warranties of Warrant Holder. Warrant
Holder represents and warrants as follows:
(a) Prior
Warrants. Warrant Holder (i) has not exercised or purported to exercise the Prior Warrants in whole or in part to purchase any
shares of Common Stock of the Company, (ii) is the sole owner and holder, beneficially and of record, of each of the Prior Warrants,
free and clear of any encumbrances, and (iii) has not assigned, transferred, sold, pledged, conveyed or otherwise disposed of the
Prior Warrants or any shares of Common Stock purchasable thereunder.
(b)
Accredited Investor. Warrant Holder is an “Accredited Investor” as such term is defined in Rule 501 of
Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”). Warrant Holder is acquiring
the New Warrants for its own account, for investment purposes only and has no current arrangements or understandings for the resale or
distribution to others and will only resell such New Warrants or any part thereof pursuant to a registration or an available exemption
under applicable law.
(c)
Investment Purpose. Warrant Holder has substantial
experience in evaluating and investing in private placement transactions of securities in companies similar to the Company so that it
is capable of evaluating the merits and risks of its investment in the Company. Warrant Holder has had an opportunity to discuss the Company’s
business, management and financial affairs with directors, officers and management of the Company and has had the opportunity to review
the Company’s operations and facilities. Warrant Holder has also had the opportunity to ask questions of and receive answers from,
the Company and its management regarding the terms and conditions of this investment. Warrant Holder acknowledges that the Company has
not delivered to Warrant Holder, and has not been requested to deliver, a private placement or similar memorandum or any written disclosure
of the types of information customarily furnished to purchasers of securities. Warrant Holder acknowledges, agrees, represents and warrants
that the Company is not making any representation or warranty, express or implied, as to the accuracy or completeness of any opinions,
projections and other forward-looking statements provided to Warrant Holder, and that none of the opinions, projections and other forward-looking
statements are, or shall be relied upon as, a promise, warranty or representation by the Company.
(d)
Exemptions. Warrant Holder understands that the New Warrants will not be registered
under the Securities Act and that it must hold the New Warrants indefinitely unless a subsequent disposition thereof is registered under
the Securities Act and applicable state securities laws or is exempt from registration.
(e)
Authorization and Compliance. The execution, delivery and performance by Warrant Holder of this Agreement, and the
consummation by Warrant Holder of the transactions contemplated hereby have been duly authorized and approved and all action required
by law to authorize the execution, delivery and performance by Warrant Holder has been duly and properly taken. This Agreement, upon its
execution and delivery as herein provided, will constitute a legal, valid and binding agreement of Warrant Holder enforceable against
it in accordance with the terms herein. Neither the execution, delivery or performance by Warrant Holder of this Agreement nor the consummation
of the transactions contemplated hereby will conflict with or result in a violation or breach of any term or provision of or constitute
a default under any contract, agreement, lease, license or other commitment to which Warrant Holder is a party or by which it or any of
its assets or properties are bound, nor violate any statute, regulation or law or any judgment, order, writ, injunction, decree, rule
or regulation of any court or administrative agency.
3.
Representations and Warranties of the Company. The
Company represents and warrants that, as of the date hereof:
(a) Organization
and Good Standing. The Company is a corporation duly organized and validly existing under the laws of the State of
Delaware, and is in good standing under such laws. The Company is qualified and authorized to do business in, and is in good
standing as a foreign corporation in, all other states in which such qualification or authorization is necessary for the conduct of
the business in which the Company is now engaged, except as would not have a material adverse effect. The Company has all necessary
material licenses and permits required by all governmental authorities to carry on the business in which the Company is now
engaged.
(b)
Authorization. The execution, delivery and performance by the Company of this
Agreement, and the consummation by the Company of the transactions contemplated hereby (including the issuance of the New Warrants), have
been duly authorized by all necessary corporate action of the Company so that (i) the New Warrants will be validly authorized and issued
and (ii) when executed and delivered, this Agreement will constitute a legal, valid and binding agreement of the Company, enforceable
against the Company in accordance with the terms herein.
(c)
Certificate of Incorporation and Bylaws. The Certificate of Incorporation and
the Bylaws of the Company (each, as amended from time to time) are in full force and effect, without further changes, amendments or modifications.
(d)
Governmental Approval. No consent or approval of any governmental agency or authority
is required in the making or performance of any of this Agreement by the Company.
(e)
Compliance. The Company is not in violation of (i) any provision of its Certificate
of Incorporation or Bylaws, (ii) any instrument, judgment, order, writ, decree or contract to which the Company is subject, or (iii) any
provision of federal, state or local law applicable to the Company or its business, where such violation, in the case of the preceding
clauses (ii) or (iii), would result in a material adverse effect on the Company. The execution, delivery and performance of this Agreement,
and the consummation of the transactions contemplated thereby, including but not limited to the issuance of the New Warrants and, subject
to any applicable shareholder approval to authorize additional shares of Common Stock, the issuance of the Common Stock underlying the
New Warrants upon exercise in accordance with the terms thereof, will not result in any violation described in the preceding sentence
or be in conflict with or constitute, with or without the passage of time and giving of notice, either a default under any provision,
judgment, order, writ, decree, contract or agreement, or require any consent, waiver or approval thereunder, or constitute an event that
results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, impairment, forfeiture,
or nonrenewal of any material permit, license, authorization or approval applicable to the Company, its business or operations or any
of its assets or properties.
4.
Further Assurances. Each of the Company and Warrant Holder agrees to take
such further action (including the execution and delivery of such further instruments and documents) as shall be reasonably necessary
to carry out the purpose of this Agreement as any party hereto may reasonably request, all at the sole cost and expense of the Company.
5.
General.
(a) Governing
Law. This Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New
York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction
of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by
mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the
address in effect for notices to it under the Pre-Paid Advance Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any other manner permitted by law.
(b)
Amendments and Waivers. Any provision of this Agreement may be amended or waived if, but only if, such amendment
or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement, or in the case of a waiver, by the
party against whom the waiver is to be effective. No failure or delay by any party in exercising any right, power or privilege hereunder
shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the
exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any
rights or remedies provided by law.
(c)
Successors and Assigns; Third Party Beneficiaries. The provisions of this Agreement shall be binding upon and inure
to the benefit of the parties hereto and their respective successors and assigns; provided that no party may assign, delegate or
otherwise transfer any of its rights or obligations under this Agreement without the consent of each other party hereto. No provision
of this Agreement is intended to confer any rights, benefits, remedies, obligations, or liabilities hereunder upon any person other than
the parties hereto and their respective successors and assigns.
(d)
Counterparts. This Agreement may be signed in any number of counterparts, each of which shall be an original, with
the same effect as if the signatures thereto and hereto were upon the same instrument.
(e)
Entire Agreement. This Agreement (taken together with the New Warrants) constitutes the entire agreement between
the parties with respect to the exchange of the Prior Warrants for the New Warrants and supersedes all prior agreements and understandings,
both oral and written, between the parties with respect to that subject matter.
(f) Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
or other governmental authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions
of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated so long as the economic
or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such a
determination, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as
closely as possible in an acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated
to the fullest extent possible.
[Signature Pages Follow]
IN WITNESS WHEREOF, the parties
hereto have executed this Warrant Cancellation and Exchange Agreement as of the date first above written.
| |
CANOO INC. |
| |
|
| |
By: |
/s/ Tony Aquila |
| |
|
Name: Tony Aquila |
| |
|
Title: Chief Executive Officer |
[Signature Page to Warrant
Cancellation and Exchange Agreement]
IN WITNESS WHEREOF, the parties
hereto have executed this Warrant Cancellation and Exchange Agreement as of the date first above written.
| |
YA II PN, LTD. |
| |
|
| |
By: |
Yorkville Advisors Global LP |
| |
Its: |
Investment Manager |
| |
|
By: |
Yorkville Advisors Global II, LLC |
| |
|
Its: |
General Partner |
| |
|
| |
By: |
/s/ Matt Beckman |
| |
|
Name: Matt Beckman |
| |
|
Title: Member |
[Signature Page to Warrant
Cancellation and Exchange Agreement]
Exhibit A
FORM OF NEW WARRANT
See attached.
WARRANT
THE SECURITIES REPRESENTED BY THIS WARRANT HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR
THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL IN A FORM REASONABLY
SATISFACTORY TO THE ISSUER THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT
TO RULE 144 UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THIS WARRANT MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT.
CANOO INC.
Warrant To Purchase Common Stock
| Warrant No.: GOEV-[_] |
Number of Shares: |
[_______] |
| |
Warrant Exercise Price: |
$0.___ |
Date of Issuance: January 31, 2024
CANOO INC., a Delaware corporation
(the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, YA II PN, Ltd. (the “Holder”), the registered holder hereof or its permitted
assigns, is entitled, subject to the terms set forth below, to purchase from the Company upon surrender of this Warrant, at any time
or times on or after the date hereof, but not after 11:59 P.M. Eastern Time on the Expiration Date (as defined herein)
[_________] fully paid and nonassessable shares of Common Stock (as defined herein) of the Company (the “Warrant
Shares”) at the exercise price per share provided in Section 1(b) below or as subsequently adjusted; provided,
however, that in no event shall the holder be entitled to exercise this Warrant for a number of Warrant Shares in excess of that
number of Warrant Shares which, upon giving effect to such exercise, would cause the aggregate number of shares of Common Stock
beneficially owned by the holder and its affiliates to exceed 4.99% of the outstanding shares of the Common Stock following such
exercise, except within sixty (60) days of the Expiration Date (however, such restriction may be waived by Holder (but only as to
itself and not to any other holder) upon not less than 65 days prior notice to the Company). For purposes of the foregoing proviso,
the aggregate number of shares of Common Stock beneficially owned by the holder and its affiliates shall include the number of
shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such proviso is being made,
but shall exclude shares of Common Stock which would be issuable upon (i) exercise of the remaining, unexercised Warrants
beneficially owned by the holder and its affiliates and (ii) exercise or conversion of the unexercised or unconverted portion
of any other securities of the Company beneficially owned by the holder and its affiliates (including, without limitation, any
convertible notes or preferred stock) subject to a limitation on conversion or exercise analogous to the limitation contained
herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in
accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended. For purposes of this Warrant, in determining the
number of outstanding shares of Common Stock a holder may rely on the number of outstanding shares of Common Stock as reflected in
(1) the Company’s most recent Form 10-Q or Form 10-K, as the case may be, (2) a more recent public announcement by the Company
or (3) any other notice by the Company or its transfer agent setting forth the number of shares of Common Stock outstanding. Upon
the written request of any holder, the Company shall promptly, but in no event later than one (1) Business Day following the receipt
of such notice, confirm in writing to any such holder the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the exercise of Warrants (as defined below) by such
holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported.
Section 1.
(a)
This Warrant is being issued pursuant to the Warrant Cancellation and Exchange Agreement (“Issuance Agreement”)
of even date herewith between the Company and the Holder or issued in exchange or substitution thereafter or replacement thereof. Each
Capitalized term used, and not otherwise defined herein, shall have the meaning ascribed thereto in the Issuance Agreement.
(b)
Definitions. The following words and terms as used in this Warrant shall have the following meanings:
(i) “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in the City
of New York are authorized or required by law to remain closed.
(ii) “Closing Bid Price” means the closing bid price of Common Stock as quoted on the Principal Market (as reported
by Bloomberg Financial Markets (“Bloomberg”) through its “Volume at Price” function).
(iii)
“Common Stock” means (i) the Company’s common stock, par value $0.001 per share, and (ii) any
capital stock into which such Common Stock shall have been changed or any capital stock resulting from a reclassification of such Common
Stock.
(iv)
“Expiration Date” means February 1, 2029. If such date falls on a Saturday, Sunday or other day on which banks
are required or authorized to be closed in the City of New York or the State of New York or on which trading does not take place on the
Principal Exchange or automated quotation system on which the Common Stock is traded (a “Holiday”), the next date that
is not a Holiday.
(v)
“Issuance Date” means the date hereof.
(vi)
“Options” means any rights, warrants or options to subscribe for or purchase Common Stock or Convertible Securities.
(vii)
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a
trust, an unincorporated organization and a government or any department or agency thereof.
(viii)
“Principal Market” means on any of (a) the American Stock Exchange, (b) New York Stock Exchange, (c) the Nasdaq
National Market, or (d) the Nasdaq Capital Market.
(ix)
“Securities Act” means the Securities Act of 1933, as amended.
(x)
“Warrant” means this Warrant and all Warrants issued in exchange, transfer or replacement thereof.
(xi)
“Warrant Exercise Price” shall be $0.[_____] or as subsequently adjusted as provided in Section 8 hereof.
(c)
Other Definitional Provisions.
(i)
Except as otherwise specified herein, all references herein (A) to the Company shall be deemed to include the Company’s
successors and (B) to any applicable law defined or referred to herein shall be deemed references to such applicable law as the same
may have been or may be amended or supplemented from time to time.
(ii)
When used in this Warrant, the words “herein”, “hereof”, and “hereunder”
and words of similar import, shall refer to this Warrant as a whole and not to any provision of this Warrant, and the words “Section”,
“Schedule”, and “Exhibit” shall refer to Sections of, and Schedules and Exhibits to, this Warrant
unless otherwise specified.
(iii)
Whenever the context so requires, the neuter gender includes the masculine or feminine, and the singular number includes the plural,
and vice versa.
Section 2. Exercise
of Warrant.
(a) Subject
to the terms and conditions hereof, this Warrant may be exercised by the holder hereof then registered on the books of the Company,
pro rata as hereinafter provided, at any time on any Business Day on or after the opening of business on such Business Day,
commencing with the first Business Day immediately following the 6-month anniversary of the Issuance Date, and prior to
11:59 P.M. Eastern Time on the Expiration Date (i) by delivery of a written notice, in the form of the subscription notice
attached as Exhibit A hereto (the “Exercise Notice”), of such holder’s election to exercise this
Warrant, which notice shall specify the number of Warrant Shares to be purchased, payment to the Company of an amount equal to
the Warrant Exercise Price(s) applicable to the Warrant Shares being purchased, multiplied by the number of Warrant Shares (at
the applicable Warrant Exercise Price) as to which this Warrant is being exercised (plus any applicable issue or transfer
taxes) (the “Aggregate Exercise Price”) in cash or wire transfer of immediately available funds and the surrender
of this Warrant (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction) to a
common carrier for overnight delivery to the Company as soon as practicable following such date (“Cash Basis”) or
(ii) if at the time of exercise, the Warrant Shares are not subject to an effective registration statement, or can be sold without
restriction or limitation pursuant to Rule 144 as promulgated under the Securities Act by delivering an Exercise Notice and in lieu
of making payment of the Aggregate Exercise Price in cash or wire transfer, elect instead to receive upon such exercise the
“Net Number” of shares of Common Stock determined according to the following formula (the “Cashless
Exercise”):
Net Number = (A x B) – (A x C)
B
For purposes of the
foregoing formula:
A = the total number of Warrant Shares with
respect to which this Warrant is then being exercised.
B = the Closing Bid Price of the Common Stock
on the date of exercise of the Warrant.
C = the Warrant Exercise Price then in effect
for the applicable Warrant Shares at the time of such exercise.
(b)
In the event of any exercise of the rights represented by this Warrant in compliance with this Section 2, the Company shall on
or before the fifth (5th) Business Day following the date of receipt of the Exercise Notice, the Aggregate Exercise Price and this
Warrant (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction) and the receipt
of the representations of the holder specified in Section 6 hereof, if requested by the Company (the “Exercise Delivery Documents”),
and if the Common Stock is DTC eligible, credit such aggregate number of shares of Common Stock to which the holder shall be entitled
to the holder’s or its designee’s balance account with The Depository Trust Company; provided, however, if the holder who
submitted the Exercise Notice requested physical delivery of any or all of the Warrant Shares, or, if the Common Stock is not DTC eligible
then the Company shall, on or before the fifth (5th) Business Day following receipt of the Exercise Delivery Documents,
issue and surrender to a common carrier for overnight delivery to the address specified in the Exercise Notice, a certificate, registered
in the name of the holder, for the number of shares of Common Stock to which the holder shall be entitled pursuant to such request. Upon
delivery of the Exercise Notice and Aggregate Exercise Price referred to in clause (i) or (ii) above the holder of this Warrant shall
be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has
been exercised. In the case of a dispute as to the determination of the Warrant Exercise Price, the Closing Bid Price or the arithmetic
calculation of the Warrant Shares, the Company shall promptly issue to the holder the number of Warrant Shares that is not disputed and
shall submit the disputed determinations or arithmetic calculations to the holder via facsimile within one (1) Business Day of receipt
of the holder’s Exercise Notice.
(c)
Principal Market Limitation. Notwithstanding anything in this Warrant to the contrary, the Company shall not issue any
shares of Common Stock pursuant to the terms of this Warrant if the issuance of such shares of Common Stock would exceed the aggregate
number of shares of Common Stock that the Company may in connection with any transaction aggregated with this Warrant in compliance with
the Company’s obligations under the rules or regulations of Nasdaq Stock Market (such amount of shares shall be referred to as the
“Exchange Cap”), except that such limitation shall not apply in the event that the Company (A) obtains the approval
of its stockholders as required by the applicable rules of the Nasdaq Stock Market for issuances of shares of Common Stock in excess of
such amount or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which opinion shall
be reasonably satisfactory to the Holder.
(d)
If the holder and the Company are unable to agree upon the determination of the Warrant Exercise Price or arithmetic calculation
of the Warrant Shares within one (1) day of such disputed determination or arithmetic calculation being submitted to the holder, then
the Company shall immediately submit via facsimile (i) the disputed determination of the Warrant Exercise Price or the Closing Bid Price
to an independent, reputable investment banking firm or (ii) the disputed arithmetic calculation of the Warrant Shares to its independent,
outside accountant. The Company shall cause the investment banking firm or the accountant, as the case may be, to perform the determinations
or calculations and notify the Company and the holder of the results no later than forty-eight (48) hours from the time it receives the
disputed determinations or calculations. Such investment banking firm’s or accountant’s determination or calculation, as the
case may be, shall be deemed conclusive absent manifest error.
(e)
Unless the rights represented by this Warrant shall have expired or shall have been fully exercised, the Company shall, as soon
as practicable and in no event later than five (5) Business Days after any exercise and at its own expense, issue a new Warrant identical
in all respects to this Warrant exercised except it shall represent rights to purchase the number of Warrant Shares purchasable immediately
prior to such exercise under this Warrant exercised, less the number of Warrant Shares with respect to which such Warrant is exercised.
(f)
No fractional Warrant Shares are to be issued upon any pro rata exercise of this Warrant, but rather the number of Warrant Shares
issued upon such exercise of this Warrant shall be rounded up or down to the nearest whole number.
(g)
If the Company or its Transfer Agent shall fail for any reason or for no reason to issue to the holder within ten (10) days
of receipt of the Exercise Delivery Documents, a certificate for the number of Warrant Shares to which the holder is entitled or to credit
the holder’s balance account with The Depository Trust Company for such number of Warrant Shares to which the holder is entitled
upon the holder’s exercise of this Warrant, the Company shall, in addition to any other remedies under this Warrant, have any other
remedies otherwise available to such holder.
(h)
If within ten (10) days after the Company’s receipt of the Exercise Delivery Documents, the Company fails to deliver a new
Warrant to the holder for the number of Warrant Shares to which such holder is entitled pursuant to Section 2 hereof, then, in addition
to any other available remedies under this Warrant, have any other remedies otherwise available to such holder.
Section 3. Covenants as
to Common Stock. The Company hereby covenants and agrees as follows:
(a)
This Warrant is, and any Warrants issued in substitution for or replacement of this Warrant will upon issuance be, duly authorized
and validly issued.
(b)
All Warrant Shares which may be issued upon the exercise of the rights represented by this Warrant will, upon issuance, be validly
issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof.
(c)
Insufficient Authorized Shares. At any time while this Warrant remains outstanding, on or after March 25, 2024, if the Company
does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve for issuance
upon exercise of this Warrant at least a number shares of Common Stock equal to 100% of the number shares of Common Stock as shall from
time to time be necessary to effect the exercise of all of this Warrant then outstanding without regard to any limitation on exercise
included herein (the “Required Reserve Amount”) then the Company shall immediately take all action necessary to increase
the Company's authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount for
this Warrant then outstanding.
(d)
If at any time after the date hereof the Company shall file a registration statement (other than a registration statement on Form
S-4, S-8 or for which the underwriter for such offering refuses in writing to include the Warrant Shares), the Company shall include the
Warrant Shares issuable to the holder, pursuant to the terms of this Warrant and shall maintain, so long as any other shares of Common
Stock shall be so listed, such listing of all Warrant Shares from time to time issuable upon the exercise of this Warrant; and the Company
shall so list on each national securities exchange or automated quotation system, as the case may be, and shall maintain such listing
of, any other shares of capital stock of the Company issuable upon the exercise of this Warrant if and so long as any shares of the same
class shall be listed on such national securities exchange or automated quotation system.
(e)
The Company will not, by amendment of its Articles of Incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities, or any other voluntary action (it being understood that filing a Certificate of Designation
or implementing a reverse split are not intended to be included in this provision), avoid or seek to avoid the observance or performance
of any of the terms to be observed or performed by it hereunder, but will at all times in good faith assist in the carrying out of all
the provisions of this Warrant and in the taking of all such action as may reasonably be requested by the holder of this Warrant in order
to protect the exercise privilege of the holder of this Warrant against dilution or other impairment, consistent with the tenor and purpose
of this Warrant. The Company will not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant
above the Warrant Exercise Price then in effect, and (ii) will take all such actions as may be necessary or appropriate in order
that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant.
(f)
This Warrant will be binding upon any entity succeeding to the Company by merger, consolidation or acquisition of all or substantially
all of the Company’s assets.
Section 4. Taxes.
The Company shall pay any and all taxes, except any applicable withholding, which may be payable with respect to the issuance and delivery
of Warrant Shares upon exercise of this Warrant.
Section 5. Warrant Holder
Not Deemed a Stockholder. Except as otherwise specifically provided herein, no holder, as such, of this Warrant shall be entitled
to vote or receive dividends or be deemed the holder of shares of capital stock of the Company for any purpose, nor shall anything contained
in this Warrant be construed to confer upon the holder hereof, as such, any of the rights of a stockholder of the Company or any right
to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation,
merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance
to the holder of this Warrant of the Warrant Shares which he or she is then entitled to receive upon the due exercise of this Warrant.
In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on such holder to purchase any securities
(upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company. Notwithstanding this Section 5, the Company will provide the holder of this Warrant with copies of the
same notices and other information given to the stockholders of the Company generally, contemporaneously with the giving thereof to the
stockholders.
Section 6. Representations
of Holder. The holder of this Warrant, by the acceptance hereof, represents that it is acquiring this Warrant and the Warrant Shares
for its own account for investment only and not with a view towards, or for resale in connection with, the public sale or distribution
of this Warrant or the Warrant Shares, except pursuant to sales registered or exempted under the Securities Act; provided, however, that
by making the representations herein, the holder does not agree to hold this Warrant or any of the Warrant Shares for any minimum or other
specific term and reserves the right to dispose of this Warrant and the Warrant Shares at any time in accordance with or pursuant to a
registration statement or an exemption under the Securities Act. The holder of this Warrant further represents, by acceptance hereof,
that, as of this date, such holder is an “accredited investor” as such term is defined in Rule 501(a)(1) of Regulation
D promulgated by the Securities and Exchange Commission under the Securities Act (an “Accredited Investor”). Upon exercise
of this Warrant the holder shall, if requested by the Company, confirm in writing, in a form satisfactory to the Company, that the Warrant
Shares so purchased are being acquired solely for the holder’s own account and not as a nominee for any other party, for investment,
and not with a view toward distribution or resale and that such holder is an Accredited Investor. If such holder cannot make such representations
because they would be factually incorrect, it shall be a condition to such holder’s exercise of this Warrant that the Company receive
such other representations as the Company considers reasonably necessary to assure the Company that the issuance of its securities upon
exercise of this Warrant shall not violate any United States or state securities laws.
Section 7. Ownership
and Transfer. The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it
may designate by notice to the holder hereof), a register for this Warrant, in which the Company shall record the name and address
of the person in whose name this Warrant has been issued, as well as the name and address of each transferee. The Company may treat
the person in whose name any Warrant is registered on the register as the owner and holder thereof for all purposes, notwithstanding
any notice to the contrary, but in all events recognizing any transfers made in accordance with the terms of this Warrant.
Section 8. Adjustment
of Warrant Exercise Price and Number of Shares. The Warrant Exercise Price and the number of shares of Common Stock issuable upon
exercise of this Warrant shall be adjusted from time to time as follows:
(a)
Adjustment of Warrant Exercise Price upon Subdivision or Combination of Common Stock. If the Company at any time after the
date of issuance of this Warrant subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of
its outstanding shares of Common Stock into a greater number of shares, any Warrant Exercise Price in effect immediately prior to such
subdivision will be proportionately reduced and the number of shares of Common Stock obtainable upon exercise of this Warrant will be
proportionately increased. If the Company at any time after the date of issuance of this Warrant combines (by combination, reverse stock
split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, any Warrant Exercise
Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares issuable upon
exercise of this Warrant will be proportionately decreased. Any adjustment under this Section 8(a) shall become effective at the
close of business on the date the subdivision or combination becomes effective.
(b)
Distribution of Assets. If the Company shall declare or make any dividend or other distribution of its assets (or rights
to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution
of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement or other
similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case:
(i)
any Warrant Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination
of holders of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record
date, to a price determined by multiplying such Warrant Exercise Price by a fraction of which (A) the numerator shall be the Closing Sale
Price of the Common Stock on the trading day immediately preceding such record date minus the value of the Distribution (as determined
in good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (B) the denominator shall be the
Closing Sale Price of the Common Stock on the trading day immediately preceding such record date; and
(ii) either
(A) the number of Warrant Shares obtainable upon exercise of this Warrant shall be increased to a number of shares equal to the
number of shares of Common Stock obtainable immediately prior to the close of business on the record date fixed for the
determination of holders of Common Stock entitled to receive the Distribution multiplied by the reciprocal of the fraction set forth
in the immediately preceding clause (i), or (B) in the event that the Distribution is of common stock of a company whose common
stock is traded on a national securities exchange or a national automated quotation system, then the holder of this Warrant shall
receive an additional warrant to purchase Common Stock, the terms of which shall be identical to those of this Warrant, except that
such warrant shall be exercisable into the amount of the assets that would have been payable to the holder of this Warrant pursuant
to the Distribution had the holder exercised this Warrant immediately prior to such record date and with an exercise price equal to
the amount by which the exercise price of this Warrant was decreased with respect to the Distribution pursuant to the terms of the
immediately preceding clause (i).
(c)
Certain Events. If any event occurs of the type contemplated by the provisions of this Section 8 but not expressly
provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other
rights with equity features other than to employees, officers, directors or consultants as compensation), then the Company’s Board
of Directors will make an appropriate adjustment in the Warrant Exercise Price and the number of shares of Common Stock obtainable upon
exercise of this Warrant so as to protect the rights of the holders of the Warrants; provided, except as set forth in Section 8(a), that
no such adjustment pursuant to this Section 8(c) will increase the Warrant Exercise Price or decrease the number of shares of Common Stock
obtainable as otherwise determined pursuant to this Section 8.
(d)
Notices.
(i)
Immediately upon any adjustment of the Warrant Exercise Price, the Company will give written notice thereof to the holder of this
Warrant, setting forth in reasonable detail, and certifying, the calculation of such adjustment.
(ii)
The Company will give written notice to the holder of this Warrant at least ten (10) days prior to the date on which the Company
closes its books or takes a record (A) with respect to any dividend or distribution upon the Common Stock, (B) with respect
to any pro rata subscription offer to holders of Common Stock or (C) for determining rights to vote with respect to any Organic Change
(as defined below), dissolution or liquidation, provided that such information shall be made known to the public prior to or in conjunction
with such notice being provided to such holder.
(iii)
The Company will also give written notice to the holder of this Warrant at least ten (10) days prior to the date on which any Organic
Change, dissolution or liquidation will take place, provided that such information shall be made known to the public prior to or in conjunction
with such notice being provided to such holder.
Section 9. Purchase
Rights; Reorganization, Reclassification, Consolidation, Merger or Sale.
(a) In
addition to any adjustments pursuant to Section 8 above, if at any time the Company grants, issues or sells any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Common
Stock (the “Purchase Rights”), then the holder of this Warrant will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which such holder could have acquired if such holder had held the
number of shares of Common Stock acquirable upon complete exercise of this Warrant immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record
holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights. In the event the holder of this
Warrant does not exercise any part of this Warrant, the Purchase Rights allocable to such unexercised portion of the Warrant shall
be automatically canceled.
(b)
Any recapitalization, reorganization, reclassification, consolidation, merger, sale of all or substantially all of the Company’s
assets to another Person or other transaction in each case which is effected in such a way that holders of Common Stock are entitled to
receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in exchange for Common Stock is
referred to herein as an “Organic Change.” Prior to the consummation of any (i) sale of all or substantially all of
the Company’s assets to an acquiring Person or (ii) other Organic Change following which the Company is not a surviving entity,
the Company will secure from the Person purchasing such assets or the successor resulting from such Organic Change (in each case, the
“Acquiring Entity”) a written agreement (in form and substance reasonably satisfactory to the holders of Warrants representing
at least two-thirds of the Warrant Shares issuable upon exercise of the Warrants then outstanding) to deliver to each holder of Warrants
in exchange for such Warrants, a security of the Acquiring Entity evidenced by a written instrument substantially similar in form and
substance to this Warrant and reasonably satisfactory to the holders of the Warrants (including an adjusted warrant exercise price equal
to the value for the Common Stock reflected by the terms of such consolidation, merger or sale, and exercisable for a corresponding number
of shares of Common Stock acquirable and receivable upon exercise of the Warrants without regard to any limitations on exercise, if the
value so reflected is less than any Applicable Warrant Exercise Price immediately prior to such consolidation, merger or sale). Prior
to the consummation of any other Organic Change, the Company shall make appropriate provision (in form and substance reasonably satisfactory
to the holders of Warrants representing a majority of the Warrant Shares issuable upon exercise of the Warrants then outstanding) to insure
that each of the holders of the Warrants will thereafter have the right to acquire and receive in lieu of or in addition to (as the case
may be) the Warrant Shares immediately theretofore issuable and receivable upon the exercise of such holder’s Warrants (without
regard to any limitations on exercise), such shares of stock, securities or assets that would have been issued or payable in such Organic
Change with respect to or in exchange for the number of Warrant Shares which would have been issuable and receivable upon the exercise
of such holder’s Warrant as of the date of such Organic Change (without taking into account any limitations or restrictions on the
exercisability of this Warrant).
Section 10. Lost, Stolen,
Mutilated or Destroyed Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company shall promptly, on receipt of
an indemnification undertaking (or, in the case of a mutilated Warrant, the Warrant), issue a new Warrant of like denomination and tenor
as this Warrant so lost, stolen, mutilated or destroyed.
Section
11. Notice. Any notices, consents, waivers or other communications required or permitted to be given under the terms of
this Warrant must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally;
(ii) upon receipt, when sent by facsimile (provided confirmation of receipt is received by the sending party transmission is
mechanically or electronically generated and kept on file by the sending party); or (iii) one Business Day after deposit with a
nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses
and facsimile numbers for such communications shall be:
| If to Holder: |
YA II PN, Ltd. |
| |
c/o Yorkville Advisors Global, LP
1012 Springfield Avenue |
| |
Mountainside, NJ 07092 |
| |
Attention: Mark Angelo |
| |
Telephone: [*****]
Email: [*****] |
| |
|
| With Copy to: |
Troy J. Rillo, Esq. |
| |
1012 Springfield Avenue |
| |
Mountainside, NJ 07092 |
| |
Telephone: [*****] |
| |
Email: [*****]
[*****] |
| |
|
| If to the Company, to: |
Canoo Inc. |
| |
19951 Mariner Avenue
Torrance, California 90503 |
| |
Attn: Tony Aquila |
| |
Email: [*****] |
| |
|
| With a copy to: |
Canoo Inc.
15520 Highway 114
Justin, TX 76247
Attention: Hector Ruiz
Email: [*****] |
| |
|
If to a holder of this Warrant, to it at the address
and facsimile number set forth on Exhibit C hereto, with copies to such holder’s representatives as set forth on Exhibit C,
or at such other address and facsimile as shall be delivered to the Company upon the issuance or transfer of this Warrant. Each party
shall provide five days’ prior written notice to the other party of any change in address or facsimile number. Written confirmation
of receipt (A) given by the recipient of such notice, consent, facsimile, waiver or other communication, (or (B) provided by
a nationally recognized overnight delivery service shall be rebuttable evidence of personal service, receipt by facsimile or receipt from
a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.
Section 12. Date. The
date of this Warrant is set forth on page 1 hereof. This Warrant, in all events, shall be wholly-void and of no effect after the
close of business on the Expiration Date.
Section 13. Amendment
and Waiver. Except as otherwise provided herein, the provisions of the Warrants may be amended and the Company may take any action
herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent
of the holders of Warrants representing at least two-thirds of the Warrant Shares issuable upon exercise of the Warrants then outstanding;
provided that, except for Section 8(a), no such action may increase the Warrant Exercise Price or decrease the number of shares or class
of stock obtainable upon exercise of any Warrant without the written consent of the holder of such Warrant.
Section 14. Descriptive
Headings; Governing Law. The descriptive headings of the several sections and paragraphs of this Warrant are inserted for convenience
only and do not constitute a part of this Warrant. The corporate laws of the State of Delaware shall govern all issues concerning the
relative rights of the Company and its stockholders. All other questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict
of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of
any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and
federal courts sitting in Union County and the United States District Court for the District of New York, for the adjudication of any
dispute hereunder or in connection herewith or therewith, or with any transaction contemplated hereby or discussed herein, and hereby
irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction
of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or
proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such
suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees
that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law.
Section 15. Waiver
of Jury Trial. AS A MATERIAL INDUCEMENT FOR EACH PARTY HERETO TO ENTER INTO THIS WARRANT, THE PARTIES HERETO HEREBY WAIVE ANY RIGHT
TO TRIAL BY JURY IN ANY LEGAL PROCEEDING RELATED IN ANY WAY TO THIS WARRANT AND/OR ANY AND ALL OF THE OTHER DOCUMENTS ASSOCIATED WITH
THIS TRANSACTION.
REMAINDER OF PAGE INTENTIONALLY LEFT BLANK
IN WITNESS WHEREOF,
the Company has caused this Warrant to be signed as of the date first set forth above.
| |
CANOO INC. |
| |
|
| |
By: |
|
| |
Name: Tony Aquila |
| |
Title: Chief Executive Officer |
EXHIBIT A TO WARRANT
EXERCISE NOTICE
TO BE EXECUTED
BY THE REGISTERED HOLDER TO EXERCISE THIS WARRANT
CANOO INC.
The undersigned holder hereby
exercises the right to purchase ______________ of the shares of Common Stock (“Warrant Shares”) of CANOO INC.
(the “Company”), evidenced by the attached Warrant (the “Warrant”). Capitalized terms used herein
and not otherwise defined shall have the respective meanings set forth in the Warrant.
Specify Method of exercise by check mark:
1. ¨ Cash Exercise
(a) Payment of Warrant Exercise
Price. The holder shall pay the Aggregate Exercise Price of $______________ to the Company in accordance with the terms of the Warrant.
(b) Delivery of Warrant Shares.
The Company shall deliver to the holder ______________Warrant Shares in accordance with the terms of the Warrant.
2. ¨
Cashless Exercise
(a) Payment of Warrant Exercise
Price. In lieu of making payment of the Aggregate Exercise Price, the holder elects to receive upon such exercise the Net Number of
shares of Common Stock determined in accordance with the terms of the Warrant.
(b) Delivery of Warrant Shares.
The Company shall deliver to the holder ______________Warrant Shares in accordance with the terms of the Warrant.
Date: _______________ __, ______
| Name of Registered Holder |
|
| |
|
| By: |
|
|
| Name: |
|
|
| Title: |
|
|
EXHIBIT B TO WARRANT
FORM OF WARRANT POWER
FOR VALUE RECEIVED,
the undersigned does hereby assign and transfer to ________________, Federal Identification No. __________, a warrant to purchase
____________ shares of the capital stock of Canoo Inc. represented by warrant certificate no. _____, standing in the name of the
undersigned on the books of said corporation. The undersigned does hereby irrevocably constitute and appoint ______________, attorney
to transfer the warrants of said corporation, with full power of substitution in the premises.
v3.24.0.1
| X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
| Name: |
dei_AmendmentFlag |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
| Name: |
dei_DocumentPeriodEndDate |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:dateItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
| Name: |
dei_DocumentType |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:submissionTypeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
| Name: |
dei_EntityAddressAddressLine1 |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
+ References
+ Details
| Name: |
dei_EntityAddressCityOrTown |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCode for the postal or zip code
| Name: |
dei_EntityAddressPostalZipCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the state or province.
| Name: |
dei_EntityAddressStateOrProvince |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:stateOrProvinceItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityCentralIndexKey |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:centralIndexKeyItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionIndicate if registrant meets the emerging growth company criteria. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityEmergingGrowthCompany |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
| Name: |
dei_EntityFileNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:fileNumberItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
| Name: |
dei_EntityIncorporationStateCountryCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarStateCountryItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityRegistrantName |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityTaxIdentificationNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:employerIdItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionLocal phone number for entity.
| Name: |
dei_LocalPhoneNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
| Name: |
dei_PreCommencementIssuerTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
| Name: |
dei_PreCommencementTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTitle of a 12(b) registered security. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
| Name: |
dei_Security12bTitle |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:securityTitleItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the Exchange on which a security is registered. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
| Name: |
dei_SecurityExchangeName |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarExchangeCodeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Section 14a
-Number 240
-Subsection 12
| Name: |
dei_SolicitingMaterial |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
| Name: |
dei_TradingSymbol |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:tradingSymbolItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
| Name: |
dei_WrittenCommunications |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
Canoo (NASDAQ:GOEV)
過去 株価チャート
から 10 2024 まで 11 2024
Canoo (NASDAQ:GOEV)
過去 株価チャート
から 11 2023 まで 11 2024
